Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer

OBJECTIVE: Triple-negative breast cancer (TNBC) is an aggressive disease with highly invasive nature and poor outcomes. Due to the absence of specific treatment strategies for this tumor subgroup, patients with TNBC are treated with conventional therapeutics, frequently leading to systemic relapse....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianzhao, Feng, Lixia, Sheng, Qinghua, Li, Lianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528587/
https://www.ncbi.nlm.nih.gov/pubmed/34691227
http://dx.doi.org/10.1155/2021/8720679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528587/
https://www.ncbi.nlm.nih.gov/pubmed/34691227
http://dx.doi.org/10.1155/2021/8720679

Ejemplares similares